The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal

Robert Roggers, Shrey Kanvinde, Suthida Boonsith, David Oupický

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability for stimulus-responsive controlled release, good cellular uptake, cell specific targeting, and the ability to carry a variety of cargoes from hydrophobic drug molecules to imaging agents. However, the translation of the in vitro findings to in vivo conditions has been slow. Herein, we review the current state-of-the-art in the use of MSN for systemic drug delivery in vivo and provide critical insight into the future of MSNs as systemic drug delivery devices and directions that should be undertaken to improve their practicality.

Original languageEnglish (US)
Pages (from-to)1163-1171
Number of pages9
JournalAAPS PharmSciTech
Volume15
Issue number5
DOIs
StatePublished - Oct 1 2014

Fingerprint

Silicon Dioxide
Nanoparticles
Equipment and Supplies
Pharmaceutical Preparations
History
In Vitro Techniques

Keywords

  • drug delivery
  • mesoporous silica
  • nanoparticles

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal. / Roggers, Robert; Kanvinde, Shrey; Boonsith, Suthida; Oupický, David.

In: AAPS PharmSciTech, Vol. 15, No. 5, 01.10.2014, p. 1163-1171.

Research output: Contribution to journalReview article

Roggers, Robert ; Kanvinde, Shrey ; Boonsith, Suthida ; Oupický, David. / The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal. In: AAPS PharmSciTech. 2014 ; Vol. 15, No. 5. pp. 1163-1171.
@article{ca627fc8054e45a79e95c543217e939a,
title = "The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal",
abstract = "Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability for stimulus-responsive controlled release, good cellular uptake, cell specific targeting, and the ability to carry a variety of cargoes from hydrophobic drug molecules to imaging agents. However, the translation of the in vitro findings to in vivo conditions has been slow. Herein, we review the current state-of-the-art in the use of MSN for systemic drug delivery in vivo and provide critical insight into the future of MSNs as systemic drug delivery devices and directions that should be undertaken to improve their practicality.",
keywords = "drug delivery, mesoporous silica, nanoparticles",
author = "Robert Roggers and Shrey Kanvinde and Suthida Boonsith and David Oupick{\'y}",
year = "2014",
month = "10",
day = "1",
doi = "10.1208/s12249-014-0142-7",
language = "English (US)",
volume = "15",
pages = "1163--1171",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "5",

}

TY - JOUR

T1 - The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal

AU - Roggers, Robert

AU - Kanvinde, Shrey

AU - Boonsith, Suthida

AU - Oupický, David

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability for stimulus-responsive controlled release, good cellular uptake, cell specific targeting, and the ability to carry a variety of cargoes from hydrophobic drug molecules to imaging agents. However, the translation of the in vitro findings to in vivo conditions has been slow. Herein, we review the current state-of-the-art in the use of MSN for systemic drug delivery in vivo and provide critical insight into the future of MSNs as systemic drug delivery devices and directions that should be undertaken to improve their practicality.

AB - Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability for stimulus-responsive controlled release, good cellular uptake, cell specific targeting, and the ability to carry a variety of cargoes from hydrophobic drug molecules to imaging agents. However, the translation of the in vitro findings to in vivo conditions has been slow. Herein, we review the current state-of-the-art in the use of MSN for systemic drug delivery in vivo and provide critical insight into the future of MSNs as systemic drug delivery devices and directions that should be undertaken to improve their practicality.

KW - drug delivery

KW - mesoporous silica

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84907875997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907875997&partnerID=8YFLogxK

U2 - 10.1208/s12249-014-0142-7

DO - 10.1208/s12249-014-0142-7

M3 - Review article

C2 - 24871552

AN - SCOPUS:84907875997

VL - 15

SP - 1163

EP - 1171

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 5

ER -